ASCO in ActionASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.

To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.

Tune in to ASCO's new ASCO in Action podcast series, providing analysis and commentary on cancer policy and practice issues, available through iTunes or Google Play.

Showing results for Congress

August 16, 2018

The American Society of Clinical Oncology (ASCO) warns that Medicaid work requirements may hinder patients’ access to essential cancer care and reduce the already limited time physicians are able to spend with their patients. In a new position statement released today, ASCO also recommends that federal and state policymakers take specific steps to ensure that new Medicaid requirements will not harm patients with cancer.  

July 31, 2018

ASCO submitted a statement to the U.S. House of Representatives Energy and Commerce Committee in conjunction with a subcommittee hearing on implementation of the Merit-Based Incentive Payment System (MIPS) under the Medicare Access and CHIP Reauthorization Act (MACRA).

July 27, 2018

On July 25, the U.S. House Energy and Commerce Committee held a hearing during which Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, Director of the National Cancer Institute (NCI) Norman Sharpless, MD, and Director of National Institutes of Health Francis Collins, MD, PhD, provided updates on how their respective agencies have been implementing the 21st Century Cures legislation.

July 16, 2018

"I Live to Conquer Cancer" is a new national outreach and awareness initiative that builds on ASCO’s continued advocacy activities in support of the National Institutes of Health (NIH) and the National Cancer Institute (NCI), and aims to underscore the critical importance of federally funded cancer research.

July 13, 2018

ASCO submitted comments to U.S. House of Representatives Energy and Commerce Committee leadership in conjunction with a subcommittee hearing on the 340B Drug Pricing Program, “Opportunities to Improve the 340B Drug Pricing Program.” In writing to Committee leadership, ASCO President Monica M. Bertagnolli, MD, FACS, FASCO, underscored ASCO’s appreciation for the committee’s continued efforts “to ensure the program addresses the needs of underserved patients—particularly their ability to access cancer care.”

June 29, 2018

The Senate Appropriations Committee approved a $2 billion funding increase to the National Institutes of Health (NIH) as part of its Fiscal Year (FY) 2019 Department of Labor, Health and Human Services (HHS), Education funding bill.

June 27, 2018

ASCO has launched a new  ACT Network site that makes it easier-than-ever to advocate on behalf of the oncology community. As the online advocacy hub for ASCO advocates, the new ACT Network offers enhanced features that allow advocates to quickly and easily engage their lawmakers on key policy issues.

June 12, 2018

Right-to-try is the latest topic addressed in the ASCO in Action podcast series. ASCO CEO Dr. Clifford Hudis recently interviewed ASCO Senior Vice President and Chief Medical Officer Dr. Richard Schilsky to examine RTT legislation—now enacted as federal law—and discuss the Food and Drug Administration’s (FDA) expanded access program.

June 5, 2018

On June 6, 2018, the One Voice Against Cancer Coalition (OVAC) will hold an “Online Day of Action” to advocate for increased funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). 

May 29, 2018

With Congress having recently passed federal "right-to-try" (RTT) legislation, ASCO has developed a suite of educational resources that will help members understand the impact of this law on cancer care and individuals with cancer. Resources include a podcast with guest ASCO Senior Vice President and Chief Medical Officer Dr. Richard Schilsky, FACP, FASCO, FSCT, an issue brief on RTT legislation, and an FAQ for oncologists and their patients.

May 23, 2018

On Tuesday, May 15, five ASCO volunteers represented the society as part of One Voice Against Cancer’s (OVAC) annual Hill Day, where 100  participants from 25 non-profit organizations met with Members of Congress and their staff to highlight the need for the government’s continued investment in the fight against cancer.

May 23, 2018

The U.S. House of Representatives passed the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act (H.R. 820/S. 292), which will help improve care for the nearly 16,000 children diagnosed with cancer in the United States every year.

May 22, 2018

On May 15, ASCO submitted comments to Congressional committees applauding their commitment to addressing the opioid crisis but urged them to ensure that such efforts do not prevent patients with cancer from receiving appropriate opioid therapy.

May 18, 2018

On May 17, the Senate Appropriations Committee held a hearing to discuss the budget request for the National Institutes of Health (NIH) for Fiscal Year (FY) 2019. NIH Director Francis Collins, MD, PhD, and National Cancer Institute (NCI) Director Ned Sharpless, MD, both gave testimony at the hearing, where Dr. Sharpless underscored the need for adequate funding to strengthen the cancer research infrastructure.

May 10, 2018

On May 8, the White House submitted a rescission package to Congress, which proposes $15 billion in cuts to 38 government programs and agencies, including to the Center for Medicare and Medicaid Innovation.

Pages